FDA and Drug Regulation

In a free society, individuals should be free to care for their physical well-being as they see fit, which includes the freedom to choose the medical treatments they think best. Such liberty does not open the door for fraud or abuse any more than does a free market in other products. In fact, informed consent by patients will become more sophisticated as the market for information about medical treatments becomes more free and open.

More on FDA and Drug Regulation

Commentary

Soda Ban Ruling a Devastating Defeat for Mayor Bloomberg

By Walter Olson. Daily Caller. March 12, 2013.

Sweet Savage Food Marketing at the New York Times

By Walter Olson. Daily Caller. February 26, 2013.

How an Anti-GM Activist Learned the Science of High-Yield Crops and Became a Campaigner for GM

By Swaminathan S. Anklesaria Aiyar. Economic Times (India). January 16, 2013.

More Commentary

Cato Studies

Avoiding Medicare’s Pharmaceutical Trap

By Doug Bandow. Policy Analysis No. 556. November 30, 2005.

Treating Doctors as Drug Dealers: The DEA’s War on Prescription Painkillers

By Ronald T. Libby. Policy Analysis No. 545. June 6, 2005.

Health Care Regulation: A $169 Billion Hidden Tax

By Christopher J. Conover. Policy Analysis No. 527. October 4, 2004.

More Cato Studies

Public Filings

IMS Health v. Sorrell

By Ilya Shapiro. Legal Briefs. July 14, 2009.

Legalizing Prescription Drug Importation

By Roger Pilon. Testimony. January 26, 2005.

A Medicare Prescription Drug Safety Net: Creating A Targeted Benefit for Low-Income Seniors

By Tom Miller. Testimony. September 24, 2003.

More Public Filings

Events

Drug Reimportation: The Free-Market Solution

Featuring . September 20, 2004. Capitol Hill Briefing.

Resolved: Congress Should Remove the Ban on Drug Reimportation

Featuring . March 30, 2004. Policy Forum.

Drug Reimportation: Time for a Free Market?

Featuring . October 31, 2003. Capitol Hill Briefing.